Spain - AI Cancer Drup Development Optimization

To develop a new drug for cancer takes 10 years. The average cost to bring an NME to market is estimated to be approximately $1.8 billion. This company reduces development time by offering a platform that uses data from difference sources including molecular-alterations, scientific results, clinical trials, combinations of compounds, described efficacy, competitive landscape, in addition to side effects or potential interactions, to provide the user with all relevant data in a customized manner, without the necessity to obtain this information through expensive consulting dossiers. It also is developing algorithms that can help to predict the success of a new pharmacological compound through the identification of unmet necessities, empty areas, potential side effects or combinations that would not reach the clinical setting, as well as crowded sectors or areas for business development.